Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases

Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases

Abstract Background Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) revealed their key role in immune regulation, offering promising therapeutic perspectives for immune and inflammatory diseases. We aimed to develop a production process of an UC-MSC-based product and then to characterize...

Full description

Saved in:
Bibliographic Details
Main Authors: Miryam Mebarki, Nathan Iglicki, Céline Marigny, Camille Abadie, Claire Nicolet, Guillaume Churlaud, Camille Maheux, Hélène Boucher, Antoine Monsel, Philippe Menasché, Jérôme Larghero, Lionel Faivre, Audrey Cras
Format: article
Language:EN
Published: BMC 2021
Subjects:
Human umbilical cord
Mesenchymal stromal cells
Immunomodulation
Inflammation
Advanced therapy medicinal product
Good manufacturing practice
Medicine (General)
R5-920
Biochemistry
QD415-436
Online Access:https://doaj.org/article/347d91d1927840198e1681f77e14c9f8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/347d91d1927840198e1681f77e14c9f8

Similar Items